celcuity.com
Get leads like Celcuity — and thousands more
Build targeted lists by tech stack, traffic, and more
Celcuity: The Precision Playbook
How a 106-person biotech is decoding cancer's master pathways for targeted therapy.
In the high-stakes world of oncology, most drugs fail because they're guessing. Celcuity isn't guessing. They're mapping the exact oncogenic pathways that drive cancer, then building therapies to shut them down with surgical precision. Their lead candidate, gedatolisib, isn't just another inhibitor—it's a comprehensive blockade of the PI3K/AKT/mTOR pathway, the master switch for many aggressive cancers.
"Targeted therapies only work when inhibiting the target pathway disrupts the oncogenic process. Celcuity's platform provides unparalleled insights into oncogenic pathways."
The Platform: Beyond Single-Target Guesswork
Celcuity's core innovation isn't a drug—it's a diagnostic platform that identifies which specific oncogenic pathways are active in a patient's tumor. This creates a closed loop: find the pathway, validate the target, develop the therapy. It's a vertically integrated approach that de-risks drug development by ensuring the target is actually driving the cancer. Their lead candidate, gedatolisib, exemplifies this by blocking the entire PI3K/AKT/mTOR (PAM) pathway—a notoriously difficult target that requires pan-inhibition to be effective.
The Growth Story: Niche Authority
With only 8,289 monthly visits, Celcuity isn't chasing mass-market traffic. Their audience is hyper-specific: researchers, clinicians, and investors searching for 'gedatolisib clinical trial reports' (160 monthly searches) and 'celcuity press releases' (190 monthly searches). The 46% direct traffic indicates a loyal, returning audience—likely oncology professionals monitoring their pipeline. This isn't a growth hack; it's a credibility signal. They're building authority in a niche where precision matters more than scale.
The tech stack reveals a pragmatic, modern approach. They use Vite for fast builds, Tailwind CSS for rapid UI development, and core-js for JavaScript standardization. Notably, they've implemented PWA (Progressive Web App) capabilities—unusual for a biotech, suggesting they value fast, reliable access to clinical data and investor materials. The presence of jQuery alongside modern frameworks hints at legacy code, but the overall stack prioritizes performance and accessibility for their specialized audience.
- Vertical integration: Platform → Therapy → Clinical validation
- Targeting the PAM pathway: A master regulator of tumor growth
- 106 employees generating $16M revenue: Lean, focused execution
- Hyper-targeted audience: 97% traffic from undefined (likely US/Canada), minimal noise
- Strong executive team: Deep oncology expertise from leadership to R&D
Celcuity isn't playing the numbers game—they're playing the precision game.
In a field where 90% of oncology drugs fail, their pathway-first approach could be the key to unlocking targeted therapy success.
What tech stack does Celcuity use?
How much traffic does Celcuity get?
Traffic & Engagement
Traffic Sources
Where is Celcuity's audience located?
What keywords does Celcuity rank for?
5 keywordsHow is Celcuity's SEO?
Open Graph Image
https://www.celcuity.com/wp-content/uploads/2025/10/Celcuity-home.webp
Meta Tags
Celcuity Block Pam. Unlock Tomorrow
Targeted therapies only work when inhibiting the target pathway disrupts the oncogenic process. Celcuity’s platform provides unparalleled insights into oncogenic pathways. We harness these insights to develop new targeted therapies for cancer patients. Our lead candidate is gedatolisib, a pan-PI3K, mTORC1/2 inhibitor that comprehensively blockades the PI3K/AKT/mTOR (PAM) pathway.
Schema Types
What is Celcuity's revenue?
Who works at Celcuity?
Loading leads...
What do customers think of Celcuity?
No Trustpilot reviews available for this company.
Frequently Asked Questions about Celcuity
What is Celcuity's Revenue?
What does Celcuity do?
How fast is Celcuity growing?
What technologies does Celcuity use?
Who are Celcuity's competitors?
Export Data
Unlock all exports
Download CSVs, JSONs & full reports
How to contact Celcuity?
Contact Information
Export celcuity.com Data
Download the complete tech stack, analytics, leads, and company data for celcuity.com in JSON or CSV format. Use it for your sales pipeline, competitive analysis, or research.
Raw JSON Data
Click "Show" to view the raw API response data
About celcuity.com
Targeted therapies only work when inhibiting the target pathway disrupts the oncogenic process. Celcuity’s platform provides unparalleled insights into oncogenic pathways. We harness these insights to develop new targeted therapies for cancer patients. Our lead candidate is gedatolisib, a pan-PI3K, mTORC1/2 inhibitor that comprehensively blockades the PI3K/AKT/mTOR (PAM) pathway.
Company Overview
celcuity.com Social Media
Contact celcuity.com
Email Addresses
Phone Numbers
Technology Stack
celcuity.com uses 14 technologies across their website including Google Fonts, PHP, WordPress, and more.
Fonts
Google Fonts
Programming Languages
PHP
CMS
WordPress
Privacy & Consent
Cookiebot
Analytics & Marketing
Google Analytics
Performance
Lazy Loading
Traffic & Audience
celcuity.com receives approximately 8.3K monthly visitors and ranks #2,319,573 globally. The website has a bounce rate of 40% with visitors viewing an average of 2.4 pages per visit. Users spend an average of 1:59 on the site.
The majority of celcuity.com's traffic comes from undefined, undefined, .
Frequently Asked Questions
What is celcuity.com?
What technologies does celcuity.com use?
How do I contact celcuity.com?
What are celcuity.com's social media accounts?
Is celcuity.com hiring?
How popular is celcuity.com?
Related Searches
This page provides publicly available information about celcuity.com. Data is collected from various public sources and may not always be up to date. For the most accurate information, please visit celcuity.com directly at https://celcuity.com.